Therapeutic contribution of pyrodoxine pyrrolidinecarboxylate. (Notes on antiseborrheic treatment).
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002986:Clinical Trials as Topic; D012628:Dermatitis, Seborrheic / Q000188:drug therapy* / Q000503:physiopathology; D003902:Detergents / Q000627:therapeutic use; D004311:Double-Blind Method; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011736:Pyridoxine / Q000494:pharmacology / Q000627:therapeutic use*; D011760:Pyrrolidinones / Q000627:therapeutic use*; D011761:Pyrrolidonecarboxylic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D012627:Sebaceous Glands / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism
D003902:Detergents; D005230:Fatty Acids, Nonesterified; D011760:Pyrrolidinones; D013739:Testosterone; D011736:Pyridoxine; D011761:Pyrrolidonecarboxylic Acid